Final answer:
IV Antiplatelet drugs have four mechanisms of action: blocking ADP binding, inhibiting thromboxane A2, interfering with glycoprotein IIb/IIIa activation, and inducing prostacyclin production.
Step-by-step explanation:
IV Antiplatelet drugs have four mechanisms of action: blocking ADP binding, inhibiting thromboxane A2, interfering with glycoprotein IIb/IIIa activation, and inducing prostacyclin production.
The four mechanisms of IV antiplatelet drugs include:
- Blocking the binding of adenosine diphosphate (ADP) to platelet receptors, preventing platelet activation
- Inhibiting the activity of thromboxane A2, which promotes platelet aggregation and vasoconstriction
- Interfering with the activation of glycoprotein IIb/IIIa receptors on platelets, preventing platelet aggregation
- Inducing the production of prostacyclin, a vasodilator and platelet aggregation inhibitor